Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026
Research and Development AI, NVIDIA, Roche

Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance graphics processing units (GPUs) across …

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026
ReproNovo

ReproNovo has appointed Mark Altmeyer as Chairman of the Board of Directors. Bringing over 35 years of experience to the …

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026
Research and Development EndoCyclic Therapeutics, FDA, endometriosis

EndoCyclic Therapeutics’ Investigational New Drug (IND) application for its lead programme, ENDO-205, has been approved by the US FDA. With …

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026
Mestag Therapeutics

Mestag has appointed Lindsey Rolfe as Chief Medical Officer (CMO) and Pascal Merchiers as Chief Development Officer (CDO). Bringing over …

Outrun Therapeutics announces its lead programme for HPV positive cancer

March 23, 2026
Research and Development HPV, Oncology, Outrun Therapeutics

Outrun Therapeutics has selected an E6AP inhibitor strategy as its lead programme for treating HPV positive head and neck cancer. …

IsomAb appoints Philip Brainin as CEO

March 19, 2026
IsomAb

IsomAb has appointed Dr Philip Brainin as CEO and member of the Board of Directors. In this new role, Dr …

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026
Manufacturing and Production Naobios, RSV, SGS

Contract Development and Manufacturing Organisation (CDMO) Naobios has partnered with SGS, a testing, inspection and certification company, to manufacture a …

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026
Qlaris Bio

Qlaris Bio, a clinical-stage biotechnology company, has appointed Fred Guerard as president and CEO. Guerard will also join the Board …

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026
Research and Development NHS, University of Huddersfield, West Yorkshire

Dr Zubir Ahmed MP, the Under-Secretary of State for Health Innovation and Safety, has visited the recently opened Emily Siddon …

AEON Biopharma appoints John Bencich as CFO

March 17, 2026
AEON Biopharma

AEON Biopharma, a biopharmaceutical company, has appointed John Bencich as Chief Financial Officer (CFO). Bringing more than 25 years of …

Canada awards CSL Seqirus with influenza pandemic vaccine contract

March 17, 2026
Manufacturing and Production CSL Seqirus, Canada, Vaccine

CSL Seqirus has been awarded a contract committing it to manufacturing and delivering influenza vaccines to support the Public Health …

Helus Pharma appoints Jill Conwell as Chief People Officer

March 16, 2026
Helus Pharma

Helus Pharma, a clinical stage pharmaceutical company focussed on developing novel serotonergic agonists (NSAs), has appointed Jill Conwell as Chief …

Coriolis Pharma opens new US headquarter and laboratory

March 16, 2026
Manufacturing and Production Coriolis Pharma, US, development

Coriolis Pharma has opened a new US headquarter and laboratory at the Alexandria Center for Advanced Technologies (ACAT) in North …

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026
Warehousing & distribution Ireland, Thermo Fisher Scientific, distribution

Thermo Fisher Scientific has announced the opening of a new 70,000sqft distribution centre in Bracetown, County Meath, Ireland, expanding its …

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026
Altimetrik

Altimetrik, an AI-first data and digital-engineering company, has appointed Dhirendra Nath as Chief Human Resources Officer (CHRO). This appointment comes …

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026
Kindeva

Kindeva, a global drug delivery contract and development organisation (CDMO), has appointed Mike Cowhig as Chief Legal Officer. Bringing over …

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026
Research and Development DiaMedica, Health Canada, preeclampsia

DiaMedica Therapeutics has received a No Objection Letter (NOL) from Health Canada, giving the company regulatory clearance to start its …

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026
Research and Development Abselion, The Engine, US

Abselion has established a US subsidiary at The Engine in Cambridge, Massachusetts in the US. The company aims to strengthen …

Latigo Biotherapeutics appoints Neha Krishnamohan as CFO and CBO

March 10, 2026
Latigo Biotherapeutics

Latigo Biotherapeutics, a clinical-stage biopharmaceutical company developing non-opioid pain medicines, announced the appointment of Neha Krishnamohan as Chief Financial Officer …

Cellbox appoints Bernd Muehlenweg as new CBO and CFO

March 9, 2026
Cellbox Solutions

Cellbox Solutions has appointed Bernd Muehlenweg as Chief Business Officer (CBO) and Chief Financial Officer (CFO). Bernd brings over 20 …

The Gateway to Local Adoption Series

Latest content